Limba
|
Evofosfamide (TH-302) is a selective hypoxia-activated prodrug targeting hypoxicregions of solid tumors with IC50of 19 nM, demonstrates 270-fold enhanced cytotoxicity under hypoxia versus their potency under aerobic conditions, stable to cytochrome P450 metabolism.
Price | 2.076,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Evofosfamide (TH-302) is a selective hypoxia-activated prodrug targeting hypoxicregions of solid tumors with IC50of 19 nM, demonstrates 270-fold enhanced cytotoxicity under hypoxia versus their potency under aerobic conditions, stable to cytochrome P450 metabolism. |